| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Addressing the diagnostic and therapeutic dilemmas of ovarian immature teratoma: Report from a clinicopathologic consensus conference
|
Pashankar, Farzana
|
|
|
173 |
C |
p. 59-70
|
artikel
|
| 2 |
Adjuvant nivolumab versus ipilimumab (CheckMate 238 trial): Reassessment of 4-year efficacy outcomes in patients with stage III melanoma per AJCC-8 staging criteria
|
Larkin, James
|
|
|
173 |
C |
p. 285-296
|
artikel
|
| 3 |
A prospective phase II study of biweekly S-1, leucovorin, and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma – The Taiwan Cooperative Oncology Group T1217 study
|
Bai, Li-Yuan
|
|
|
173 |
C |
p. 123-132
|
artikel
|
| 4 |
Epigenetic gene alterations in metastatic solid tumours: results from the prospective precision medicine MOSCATO and MATCH-R trials
|
Martin-Romano, Patricia
|
|
|
173 |
C |
p. 133-145
|
artikel
|
| 5 |
Estimating long-term mortality in women with hormone receptor-positive breast cancer: The ‘ESTIMATE’ tool
|
Leone, José P.
|
|
|
173 |
C |
p. 20-29
|
artikel
|
| 6 |
Exposure to artificial light at night: A common link for obesity and cancer?
|
Muscogiuri, Giovanna
|
|
|
173 |
C |
p. 263-275
|
artikel
|
| 7 |
First-in-human phase I study of TQ-B3139 (CT-711) in advanced non-small cell lung cancer patients with ALK and ROS1 rearrangements
|
Ma, Yuxiang
|
|
|
173 |
C |
p. 238-249
|
artikel
|
| 8 |
First-line fluoropyrimidine plus bevacizumab followed by irinotecan-escalation versus initial fluoropyrimidine, irinotecan and bevacizumab in patients with metastatic colorectal cancer – Final survival and per-protocol analysis of the randomised XELAVIRI trial (AIO KRK 0110)
|
Stahler, Arndt
|
|
|
173 |
C |
p. 194-203
|
artikel
|
| 9 |
FOLFOX plus panitumumab or FOLFOX alone as additive therapy following R0/1 resection of RAS wild-type colorectal cancer liver metastases – The PARLIM trial (AIO KRK 0314)
|
Modest, Dominik Paul
|
|
|
173 |
C |
p. 297-306
|
artikel
|
| 10 |
Hepatocellular and extrahepatic cancers in non-alcoholic fatty liver disease: A systematic review and meta-analysis
|
Thomas, James A.
|
|
|
173 |
C |
p. 250-262
|
artikel
|
| 11 |
Impact of pharmacodynamic biomarkers in immuno-oncology phase 1 clinical trials
|
Salawu, Abdulazeez
|
|
|
173 |
C |
p. 167-177
|
artikel
|
| 12 |
Implications of the PEARL trial from the low- to middle-income countries’ perspectives
|
Reinert, Tomás
|
|
|
173 |
C |
p. 30-32
|
artikel
|
| 13 |
Incorporating progesterone receptor expression into the PREDICT breast prognostic model
|
Grootes, Isabelle
|
|
|
173 |
C |
p. 178-193
|
artikel
|
| 14 |
Influence of the SARS-CoV-2 outbreak on management and prognosis of new lung cancer cases, a retrospective multicentre real-life cohort study
|
Priou, Sonia
|
|
|
173 |
C |
p. 33-40
|
artikel
|
| 15 |
Long-term follow-up of nilotinib in patients with advanced tenosynovial giant cell tumours
|
Spierenburg, Geert
|
|
|
173 |
C |
p. 219-228
|
artikel
|
| 16 |
Long-term prognostic significance of HER2-low and HER2-zero in node-negative breast cancer
|
Almstedt, Katrin
|
|
|
173 |
C |
p. 10-19
|
artikel
|
| 17 |
MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients
|
Saint-Ghislain, Mathilde
|
|
|
173 |
C |
p. 105-112
|
artikel
|
| 18 |
Microsatellite instability and sex differences in resectable gastric cancer – A pooled analysis of three European cohorts
|
Quaas, Alexander
|
|
|
173 |
C |
p. 95-104
|
artikel
|
| 19 |
Model soups improve performance of dermoscopic skin cancer classifiers
|
Maron, Roman C.
|
|
|
173 |
C |
p. 307-316
|
artikel
|
| 20 |
Nivolumab induces long-term remission in a patient with fusariosis
|
Khatamzas, Elham
|
|
|
173 |
C |
p. 91-94
|
artikel
|
| 21 |
Overdiagnosis of invasive breast cancer in population-based breast cancer screening: A short- and long-term perspective
|
Ding, Lilu
|
|
|
173 |
C |
p. 1-9
|
artikel
|
| 22 |
Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas
|
Pearson, Andrew DJ.
|
|
|
173 |
C |
p. 71-90
|
artikel
|
| 23 |
Phase II study of the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE)
|
Higashiyama, Takuya
|
|
|
173 |
C |
p. 210-218
|
artikel
|
| 24 |
Radium-223 for patients with metastatic castration-resistant prostate cancer with asymptomatic bone metastases progressing on first-line abiraterone acetate or enzalutamide: A single-arm phase II trial
|
Carles, Joan
|
|
|
173 |
C |
p. 317-326
|
artikel
|
| 25 |
Severe ototoxicity associated with immune checkpoint inhibitors (ICI) in advanced melanoma
|
Boutros, Celine
|
|
|
173 |
C |
p. 204-206
|
artikel
|
| 26 |
Survival after breast cancer in women with a subsequent live birth: Influence of age at diagnosis and interval to subsequent pregnancy
|
Anderson, Richard A.
|
|
|
173 |
C |
p. 113-122
|
artikel
|
| 27 |
Tankyrase-selective inhibitor STP1002 shows preclinical antitumour efficacy without on-target toxicity in the gastrointestinal tract
|
Kim, Dong Young
|
|
|
173 |
C |
p. 41-51
|
artikel
|
| 28 |
The impossibility of mortality evaluation of skin cancer screening in Germany based on health insurance data: a case–control study
|
Stang, Andreas
|
|
|
173 |
C |
p. 52-58
|
artikel
|
| 29 |
The sensitivity of pan-TRK immunohistochemistry in solid tumours: A meta-analysis
|
Hondelink, Liesbeth M.
|
|
|
173 |
C |
p. 229-237
|
artikel
|
| 30 |
Three-year disease-free remission in a xeroderma pigmentosum patient after adjuvant anti-PD-1 therapy
|
Scheer, Valerie
|
|
|
173 |
C |
p. 207-209
|
artikel
|
| 31 |
Triplet therapy with androgen deprivation, docetaxel, and androgen receptor signalling inhibitors in metastatic castration-sensitive prostate cancer: A meta-analysis
|
Ciccarese, Chiara
|
|
|
173 |
C |
p. 276-284
|
artikel
|
| 32 |
What a woman needs to know about overdiagnosis to decide about breast cancer screening
|
Giorgi Rossi, Paolo
|
|
|
173 |
C |
p. 327-328
|
artikel
|
| 33 |
What should be done in terms of fertility preservation for patients with cancer? The French 2021 guidelines
|
Rives, Nathalie
|
|
|
173 |
C |
p. 146-166
|
artikel
|
Tijdschrift beschrijving